Related Experiment Video
Updated: May 26, 2026

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
What are the differences in outcomes between right-sided active infective endocarditis with and without left-sided
Abderahman Kamaledeen1, Christopher Young, Rizwan Q Attia
1Department of Cardiothoracic Surgery, St Thomas' Hospital, London, UK.
Insights
Surgical outcomes for isolated right-sided infective endocarditis (RSE) are more favorable than for left-sided or combined RSE. Patients with isolated RSE experience lower early and late mortality rates following surgical management.
Area of Science:
- Cardiac Surgery
- Infective Endocarditis
- Clinical Outcomes
Background:
- Infective endocarditis (IE) can affect either the right or left side of the heart, or both.
- Surgical management is a critical treatment option for IE, but outcomes may vary based on the location of the infection.
Purpose of the Study:
- To compare the surgical outcomes of isolated right-sided infective endocarditis (RSE) with those of left-sided infective endocarditis (LSE) and combined right- and left-sided infective endocarditis (RLSE).
Main Methods:
- A systematic review of best evidence was conducted, analyzing 419 papers.
- Six studies were selected to address the clinical question regarding surgical outcomes in different IE presentations.
Main Results:
- Isolated RSE demonstrated significantly lower mortality rates compared to LSE and RLSE.
- Patients with RLSE presented with poorer pre-operative conditions and experienced a more complicated intra-operative course.
- Mortality rates for LSE were considerably higher than for isolated RSE.
Conclusions:
- Surgical management outcomes are more favorable for patients with isolated RSE.
- Isolated RSE is associated with lower early and late mortality compared to pure LSE or combined RLSE.
Abstract:
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: in patients with isolated right-sided infective endocarditis (RSE) is the outcome of surgical management the same as in patients with or without left-sided involvement? Altogether, 419 papers were found using the reported search, six of which represented the best evidence to answer the clinical question. Two studies point towards better outcomes with isolated RSE. In one paper, mortality was significantly lower in isolated RSE patients (P = 0.0093) for the duration of the follow-up time (median 488 patient-years). Two studies reported early mortality (<30 days) for RSE patients at 3.6 and 3.8%, respectively. Combined right- and left-sided endocarditis (RLSE) patients were found to have a poorer pre-operative clinical presentation than isolated RSE patients with a greater requirement for inotropic support (P < 0.006) and the likelihood of an emergency operation (P < 0.001). They had a poorer intra-operative course with a higher incidence of cardiac abscess formation (P < 0.001). One study suggested that there is no significant difference in in-hospital and long-term mortality between intravenous drug abuse (IVDA) patients and non-IVDA patients. Left-heart involvement in the IVDA group was 61.5%. This was in-line with the published literature, demonstrating a rise in RLSE in IVDA compared with non-IVDA patients. Three articles looking at isolated left-sided endocarditis (LSE) gave mortality rates in the surgical group to be 27.1, 27.8 and 38%, respectively. In one study, the LSE mortality was not different for native vs. prosthetic valve infection (OR 0.65, 95% CI 0.23-1.87). After propensity matching and adjusting for hazards, the complication rate in the LSE group was higher and this translated to a higher mortality rate. We conclude from the literature that outcomes are more favourable with lower early and late mortality for isolated RSE patients over pure LSE or combined RLSE.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests